Tuberculosis in kidney transplant candidates and recipients

doi:10.5500/wjt.v14.i3.96225

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (53)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=47

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=3

Sep 18, 2024 (publication date) through Aug 1, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transplant. Sep 18, 2024; 14(3): 96225
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.96225

Tuberculosis in kidney transplant candidates and recipients

Pallavi Prasad, Sourabh Sharma, Subashri Mohanasundaram, Anupam Agarwal, Himanshu Verma

Pallavi Prasad, Sourabh Sharma, Anupam Agarwal, Himanshu Verma, Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, Delhi, India

Subashri Mohanasundaram, Department of Nephrology, Prashanth Hospital, Chennai 600042, Tamil Nādu, India

Author contributions: Prasad P, Sharma S, and Mohanasundaram S formed the outline of the review article; Prasad P, Sharma S, Mohanasundarm S, Agarwal A, and Verma H reviewed data and wrote individual sections in the first draft; Sharma S created the infographic; Prasad P edited the final draft before submission; Prasad P, Mohanasundaram S, and Sharma S worked on editing and revising the article after peer review; All authors have read and approved the final draft.

Conflict-of-interest statement: None of the authors have any conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Pallavi Prasad, MBBS, MD, DNB, Assistant Professor, Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar East, Near AIIMS metro station, New Delhi 110029, Delhi, India. pallaviprasad1986@gmail.com

Received: April 30, 2024
Revised: June 6, 2024
Accepted: July 4, 2024
Published online: September 18, 2024
Processing time: 92 Days and 3.3 Hours

Core Tip

Core Tip: The management of tuberculosis (TB) in transplant candidates and recipients is evolving rapidly. The use of new techniques for detecting TB infection (TBI) and the adoption of TBI screening by developing countries is bringing the world closer to the World Health Organization's goal of ending the TB epidemic by 2030. Literature regarding the acceptance of kidney transplant candidates and donors after intensive phase antitubercular therapy (ATT) is now available. Fluoroquinolone-based nonrifamycin ATT has shown excellent results in transplant recipients. The review incorporates the latest guidelines and gives an overview of current evidence in the field of TB in kidney transplantation with a glimpse into the future of this field.